Dynavax Technologies
DVAX
$11.99
Share price
1.44%
Change (1 day)
4.44%
Change (1 year)
Categories
Dynavax Technologies (DVAX) - P/B ratio
P/B ratio as of June 2024 : 2.50
According to Dynavax Technologies
's latest financial reports the company has a price-to-book ratio of 2.50.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Dynavax Technologies - P/B ratio (from 2004 to 2024)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2024-12-31 | N/A | -100% |
| 2023-12-31 | 2.90 | 24.33% |
| 2022-12-31 | 2.34 | -69.22% |
| 2021-12-31 | 7.59 | -9.15% |
| 2020-12-31 | 8.35 | -85.56% |
| 2019-12-31 | 57.9 | 534.5% |
| 2018-12-31 | 9.12 | 60.61% |
| 2017-12-31 | 5.68 | 232.84% |
| 2016-12-31 | 1.71 | -65.64% |
| 2015-12-31 | 4.97 | 12.48% |
| 2014-12-31 | 4.41 | 59.65% |
| 2013-12-31 | 2.76 | -39.06% |
| 2012-12-31 | 4.54 | 7.63% |
| 2011-12-31 | 4.22 | -40.63% |
| 2010-12-31 | 7.10 | -41.27% |
| 2009-12-31 | 12.1 | 483.38% |
| 2008-12-31 | 2.07 | -60.1% |
| 2007-12-31 | 5.19 | 12.62% |
| 2006-12-31 | 4.61 | 244.02% |
| 2005-12-31 | 1.34 | -57.63% |
| 2004-12-31 | 3.16 | |
| 2003-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | 1.73 | -30.98% | 🇺🇸 USA |
 Amgen AMGN | 32.2 | 1,185.29% | 🇺🇸 USA |
 Biogen BIIB | 2.11 | -15.80% | 🇺🇸 USA |
 Gilead Sciences GILD | 4.57 | 82.84% | 🇺🇸 USA |
 Merck MRK | 7.89 | 215.34% | 🇺🇸 USA |
 AstraZeneca AZN | 6.35 | 153.84% | 🇬🇧 UK |
 GlaxoSmithKline GSK | 5.51 | 120.24% | 🇬🇧 UK |
 Agenus
AGEN | -1.67 | -166.65% | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | 2.54 | 1.44% | 🇮🇱 Israel |